About us
4D Lifetec AG is a highly innovative Swiss start-up founded 2014 and led by an experienced motivated team of experts to create a footprint in the world of cancer diagnostics. The company has developed its proprietary and fully patented 4D Lifetest™ for the early detection of cancer based on a new innovative biomarker and liquid biopsy. The assay has been successfully clinically tested and shows an unprecedented potential in the early detection of cancer. The first application just received CE mark for the use in personalized lung cancer diagnostics.
A dedicated Management Team supported by Key Experts
4D Lifetec AG is a highly innovative Swiss start up founded 2014 by Dr. Arne Faisst and Nick Mijnssen. We have set up an experienced motivated team of experts to create a footprint in the world of cancer diagnostics. Reaching today’s status, 4D Lifetec AG needs more hands to maintain dynamics and consolidate processes and services with our partners, suppliers and customers. A scientific board is currently institutionalized and expanded.
Team
-
Exec. MBA at Lorange Institute of Business, Zurich and University of Wales, Cardiff
-
PhD in Technical Mineralogy at University of Berne
-
MSc in Mineralogy at University of Berne
-
Active in the Medtech Industry (Synthes, Mathys, Heraeus) since 2001 in various national and international positions
-
Experienced global executive with broad and deep understanding of healthcare markets and working experience from Science to Sales
-
Since 2014 engaged in active trust management at anfass Life Technologies AG
-
Since 2006 Member of Executive Committee and Treasurer of Swiss Society for Biomaterials and Regenerative Medicine
-
Exec. MBA at China Europe International Business School
-
MBA at Lorange Institute of Business, Zurich
-
PhD in Biochemistry at University of Zurich
-
Dipl. Ing. in Chemistry at TU Darmstadt
- Active in Life science and Laboratory automation since 2007 in various positions
- Extensive international project management experiences in laboratory automation and life science
- PhD in Cancer Biology and Oncology
- Extensive experience in the field of translational cancer biomarkers and tumor immunology working at renowned European universities
- Specialist for clinical reseach and Liquid Biopsy
- PhD in Molecular Genetics at the Université Côte d’Azur, France
- Master in Molecular Cell Biology and Immunology
- Specialist for CRISPR/Cas9-based genetic modifikation of human cells, quantitative PCR, Digital Droplet PCR (ddPCR), RTPCR, DNA and RNA NGS-Sequenzing (Illumina, Oxford Nanopore)
- PhD in Molecular Biology
- Editor
- Experienced pharma R&D professional and biomarker scientist
- Deep expertise in diagnostically, pre-clinically and clinically applied nucleic acid analytical technologies
Doris Colussi
Finance
Board Member
-
Exec. MBA at State University at Albany, New York
-
PhD in Virology at University of Göttingen
-
MSc in Biochemistry at University of Göttingen
- Active in the Medtech Industry since 1989 (Fresenius, Synthes, Mathys, Cendres+Métaux) in various national and international positions in Germany, France, US, Netherlands and Switzerland
- Long term experience in the field of Life Science (Biochemistry, Molecular Cell Biology and Virology)
- 8 years CEO and Member of Board of Directors of the Mathys Group.
- Since 2013 owner and CEO of anfass Life Technologies AG, family office and service provider for Active Trust Management
- Experienced manager with deep understanding of healthcare markets in Europe, Asia and the US
Nick Mijnssen
Board-Member, co-Founder- Board Member since 2014
- Board of directors mandates in the field of Online Media, Startups, Project Development
- Studies in History and Philology
- Founder/President Zentralplus AG
- Former President Elchrom Scientific AG
- Board Member since 2017
- Holds various board of directors mandates in the field of home care, social enterprises and outdoor activities
- Diploma of KV Business School Zurich
- Independent specialist in finance, accounting and administration
- Former President and CEO of Cendres+Métaux Holding SA, a manufacturer of high-precision, micromechanical parts for the medtech and watch industry
- Former President and CEO of DT Swiss Group AG, a global manufacturer of high-performance cycling components
- Former Finance, Accounting & Administration Manager for various Nestlé companies in Asia
- World wide experienced in management of multicultural teams and project groups in various business fields
- Board Member since 2020
- Holds various board of directors’ mandates with diagnostics and pharmaceutical companies
- Active in Healthcare, Diagnostics and Pharmaceutical industry
- Business Consultant since 2017
- Studies in Oncology, Precision Medicine, COVID-19, Clinical Trial management, Licensing
- PhD, Diploma from Heidelberg University in Molecular Biology and Pharmacology
- Independent specialist in Precision Medicine and Companion Diagnostics
- Former Vice President Roche, Genentech, Danaher, Leica Biosystems, QIAGEN, entrepreneur and CEO of CellControl & Megamedics in Busienss development and Pharma Partnerships
